First Actin-binding Protein, circa 1975

Inverted tubes of gelled macrophage supernate (left) and water (right) for comparison. Credit: © Stossel, T.P., and J.H. Hartwig originally published in J Cell Biol 68:602-619, 1976." />Inverted tubes of gelled macrophage supernate (left) and water (right) for comparison. Credit: © Stossel, T.P., and J.H. Hartwig originally published in J Cell Biol 68:602-619, 1976. It w

Written byMegan Scudellari
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It was 1975, and Thomas Stossel and John Hartwig were baffled by the "ugly precipitate" in the bottom of their test tube. Eager young biologists, the Harvard friends had set out to solve the mystery of how cells crawl. The field of cell movement was abuzz with the revelation that non-muscle cells contained actin and myosin, but no one understood the mechanism regulating those cytoskeleton proteins. Many researchers believed the protein contractions were controlled by calcium, similar to muscle cells. Stossel and Hartwig decided to purify myosin from white blood cells as a way to find the "magic calcium stuff," recalls Stossel. Instead, their test tube was filled with some "contaminant": A high molecular weight polymer they would soon identify as the first actin-binding protein, later called filamin A.

The pair hypothesized that their protein was responsible for the transformation of cytoplasm from a liquid to gel that occurs as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas